ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Integrated Morphological, Functional, and Genomic Analysis of a Novel Lytic Phage (VIT_AJPSC) Infecting Multidrug-Resistant Shigella dysenteriae.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacteria are historically known to cause a disproportionate number of deaths because of infectious diseases worldwide. Annually, 55 million deaths are accounted for because of bacterial infections, out of which approximately 3 million deaths are because of diarrhoea and dysentery. Shigellosis is an infectious disease caused by Shigella species, and it targets the intestinal tract. It is characterised by acute diarrhoea mixed with blood. The oral antibiotics recommended for shigellosis are ciprofloxacin and azithromycin, with ciprofloxacin as the first-line treatment. Recently, Shigella species have shown a rapid increase in resistance to these antibiotics, which is leading to overdose and prolonged treatment for the same. There is a need of the hour to find a potential substitute for antibiotics. Many alternatives, such as antimicrobial peptides, plant-based substances, bacteriophages, and probiotics, have shown promise compared to antibiotics. This paper focuses on the isolation and characterization of bacteriophages against Shigella dysenteriae. Bacteriophages are viruses that kill bacteria and are very specific to their host. They require host machinery to replicate; therefore, there is very little chance of developing resistance in bacteria against phage. The paper describes screening and isolation of phages from environmental samples against Shigella dysenteriae, followed by optimization studies and their characterization, such as host range, burst size and one-step growth curve. Morphological characterization using transmission electron microscopy (TEM) and whole genome sequencing has been performed, indicating that the phage belongs to the Myoviridae family and has a genome size of 38kbp.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.